Szczegóły publikacji
Opis bibliograficzny
Reverse innovation: circumvent digital health transformation issues / Michael FRIEBE // W: Novel innovation design for the future of health : entrepreneurial concepts for patient empowerment and health democratization / ed. Michael Friebe. — Cham : Springer Nature Switzerland, cop. 2022. — Softcover ISBN 978-3-031-08193-4. — ISBN: 978-3-031-08190-3; e-ISBN: 978-3-031-08191-0. — S. 485–495. — Bibliogr., Abstr. — Publikacja dostępna online od: 2022-11-27. — Dod. afiliacje: Otto-von-Guericke University, Magdeburg ; IDTM GmbH, Recklinghausen ; FOM University of Applied Science, Center for Innovation and Business Development, Essen, Germany
Autor
Słowa kluczowe
Dane bibliometryczne
| ID BaDAP | 145650 |
|---|---|
| Data dodania do BaDAP | 2023-03-07 |
| DOI | 10.1007/978-3-031-08191-0_39 |
| Rok publikacji | 2022 |
| Typ publikacji | rozdział w podręczniku |
| Otwarty dostęp |  |
| Wydawca | Springer |
Abstract
Exponential technologies are generally described as something that will in a given time period double data generation/evaluation and/or half the associated cost with it. A Medical technology example is the cost of genome sequencing that has dropped from millions to thousands and now to under USD 1.000 within a little more than a decade. In many other areas, there is a potential and hope that certain technologies could lead to significant clinical knowledge gains and procedure improvements combined with dramatic cost reductions and increased clinical and patient satisfaction. Specifically the increasing life expectancy and the aging societies in combination with less and less available healthcare staff, ever-increasing cost associated with healthcare delivery/products and services, or the inequalities between rural and urban areas, particularly in developing nations, need to be addressed urgently. This paper will discuss some developments with a particular focus on reverse innovation, where new technologies and delivery approaches will be implemented in areas with existing health access inequalities or limited access, low quality of health service, and other urging needs (e.g., general availability and cost issues). A desire of a local government to increase population-, public-, and individual- health by allowing access of new tools despite missing regulatory approval would additionally be helpful.